A Study to Evaluate the Early Metabolic Treatment Response to Erlotinib in Patients with Advanced Non-Small-Cell-Lung-Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Dec 2015 New trial record